The folate receptor: what does it promise in tissue-targeted therapeutics?
- PMID: 17333345
- DOI: 10.1007/s10555-007-9048-0
The folate receptor: what does it promise in tissue-targeted therapeutics?
Abstract
For over a decade the folate receptor has been intensively investigated as a means for tumor-specific delivery of a broad range of experimental therapies including several conceptually new treatments. Despite a few set backs in clinical trials, the literature is replete with encouraging in vitro and pre-clinical studies of gynecological and other tumors and more therapeutic approaches are ready for clinical testing. Recent studies have added myelogenous leukemias to the list of candidate cancers for FR-targeted therapies. Each approach faces unique challenges in translation that could be addressed through a mechanistic understanding of the function and expression of the receptor in the appropriate experimental systems and by improvements in the technology. This review discusses FR in the context of positive recent developments in broad areas of FR-targeted therapy and attempts to highlight its potential and the anticipated challenges.
Similar articles
-
Folate-targeted chemotherapy.Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41. doi: 10.1016/j.addr.2004.01.008. Adv Drug Deliv Rev. 2004. PMID: 15094211 Review.
-
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy.Adv Drug Deliv Rev. 2004 Apr 29;56(8):1067-84. doi: 10.1016/j.addr.2004.01.001. Adv Drug Deliv Rev. 2004. PMID: 15094207 Review. No abstract available.
-
Folate-targeted drug strategies for the treatment of cancer.Curr Opin Investig Drugs. 2008 Dec;9(12):1277-86. Curr Opin Investig Drugs. 2008. PMID: 19037834 Review.
-
Tumor detection using folate receptor-targeted imaging agents.Cancer Metastasis Rev. 2008 Dec;27(4):655-64. doi: 10.1007/s10555-008-9155-6. Cancer Metastasis Rev. 2008. PMID: 18523731 Review.
-
Antifolates targeted specifically to the folate receptor.Adv Drug Deliv Rev. 2004 Apr 29;56(8):1111-25. doi: 10.1016/j.addr.2004.01.003. Adv Drug Deliv Rev. 2004. PMID: 15094210 Review.
Cited by
-
Simple fluorescence chemosensor for the detection of calcium ions in water samples and its application in bio-imaging of cancer cells.RSC Adv. 2022 Nov 3;12(49):31535-31545. doi: 10.1039/d2ra04815a. eCollection 2022 Nov 3. RSC Adv. 2022. PMID: 36380939 Free PMC article.
-
Tumor Targeting Effect of Triphenylphosphonium Cations and Folic Acid Coated with Zr-89-Labeled Silica Nanoparticles.Molecules. 2020 Jun 25;25(12):2922. doi: 10.3390/molecules25122922. Molecules. 2020. PMID: 32630467 Free PMC article.
-
The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.Drug Metab Dispos. 2014 Apr;42(4):632-49. doi: 10.1124/dmd.113.055723. Epub 2014 Jan 6. Drug Metab Dispos. 2014. PMID: 24396145 Free PMC article. Review.
-
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.J Clin Oncol. 2017 Apr 1;35(10):1112-1118. doi: 10.1200/JCO.2016.69.9538. Epub 2016 Dec 28. J Clin Oncol. 2017. PMID: 28029313 Free PMC article. Clinical Trial.
-
Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy.Theranostics. 2020 Jul 9;10(18):8111-8129. doi: 10.7150/thno.47865. eCollection 2020. Theranostics. 2020. PMID: 32724461 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
